Smart nanoparticles for drug delivery: Boundaries and opportunities

Chemical Engineering Science

Volumn 125, Issue , 2015, Pages 158-164

  Lee, Byung Kook ^a   Yun, Yeon Hee ^a   Park, Kinam ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Liposome; Nanocrystal; Nanoparticle; Polymer micelle; Poorly soluble drug; Targeted drug delivery

Indexed keywords

BIOCHEMISTRY; DRUG DELIVERY; DRUG INTERACTIONS; LIPOSOMES; MICROCRYSTALS; NANOCRYSTALS; TUMORS;

CLINICAL APPLICATION; DRUG DELIVERY SYSTEM; NANOPARTICLE FORMULATION; NANOPARTICLE SYSTEMS; PHARMACEUTICAL PARTICLES; POLYMER MICELLES; POORLY SOLUBLE DRUGS; TARGETED DRUG DELIVERY;

NANOPARTICLES;

EID: 84922311205     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2014.06.042     Document Type: Article

References (47)

1. ASTM, 2456-06 Standard Terminology Relating to Nanotechnology, . http://www.astm.org/Standards/E2456.htm.
2. Allen T.M., Cullis P.R. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev. 2013, 65:36-48.
3. Bae Y.H., Park K. Targeted drug delivery to tumors: myths, reality, and possibility. J. Controlled Release 2011, 153:198-205.
4. Bangham A.D., Horne R.W. Negative staining of phospholipids and their structural modification by surface active agents as observed in the electron microscope. J. Mol. Biol. 1964, 8:660-668.
5. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 2012, 64(Suppl.):206-212.
6. Chen H., Kim S., Li L., Wang S., Park K., Cheng J.-X. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Förster resonance energy transfer imaging. Proc. Nat. Acad. Sci. U.S.A. 2008, 105:6596-6601.
7. Cho K., Wang X.u., Nie S., Chen Z.G., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 2008, 14:1310-1316.
8. Cooper E.R. Nanoparticles: a personal experience for formulating poorly water soluble drugs. J. Controlled Release 2010, 141:300-302.
9. Crommelin D.J.A., Florence A.T. Towards more effective advanced drug delivery systems. Int. J. Pharm. 2013, 454:496-511.
10. Decker C., Schubert H., May S., Fahr A. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration. J. Controlled Release 2013, 166:277-285.
11. Dokoumetzidis A., Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int. J. Pharm. 2006, 321:1-11.
12. Faraday M. Experimental relations of gold (and other metals) to light. Philos. Trans. R. Soc. London 1857, 147:145-181.
13. Florence A.T. Targeting nanoparticles: the constraints of physical laws and physical barriers. J. Controlled Release 2012, 164:115-124.
14. Gao L., Liu G., Ma J., Wang X., Zhou L., Li X. Drug nanocrystals: in vivo performances. J. Controlled Release 2012, 160:418-430.
15. Grainger D.W. Connecting drug delivery reality to smart materials design. Int. J. Pharm. 2013, 454:521-524.
16. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessles: role of tumor type and microenvironment. Proc. Nat. Acad. Sci. U.S.A. 1998, 95:4607-4612.
17. Hollis C.P., Weiss H.L., Leggas M., Evers B.M., Gemeinhart R.A., Li T. Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J. Controlled Release 2013, 172:12-21.
18. ISO/TS, 27687:2008 Nanotechnologies-Terminology and Definitions for Nano Objects-Nanoparticle, Nanofibre and Nanoplate, . http://www.iso.org/iso/home/standards_development/list_of_iso_technical_committees/iso_technical_committee.htm?commid=381983.
19. Irvine D.J. Drug delivery: one nanoparticle, one kill. Nat. Mater. 2011, 10:342-343.
20. Issels R.D., Lindner L.H., Verweij J., Wust P., Reichardt P., Schem B.C., Abdel-Rahman S., Daugaard S., Salat C., Wendtner C.M., Vujaskovic Z., Wessalowski R., Jauch K.W., Dürr H.R., Ploner F., Baur-Melnyk A., Mansmann U., Hiddemann W., Blay J.Y., Hohenberger P. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010, 1:561-570.
21. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., Marks J.D., Benz C.C., Park J.W. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006, 66:6732-6740.
22. Kreuter J., Speiser P. in vitro studies of poly(methylmethacrylate) adjuvants. J. Pharm. Sci. 1976, 65:1624-1627.
23. Kwon I.K., Lee S.C., Han B., Park K. Analysis on the current status of targeted drug delivery to tumors. J. Controlled Release 2012, 164:108-114.
24. Lee B.K., Yun Y.H., Park K., Sturek M. Introduction to biomaterials for cancer therapeutics. Biomaterials for Cancer Therapeutics 2013, Woodhead Publishing Ltd., Oxford, UK. K. Park (Ed.).
25. Li L., ten Hagen T.L.M., Haeri A., Soullié T., Scholten C., Seynhaeve A.L.B., Eggermont A.M.M., Koning G.A. A novel two-step mild hyperthermia for advanced liposomal chemotherapy. J. Controlled Release 2014, 174:202-208.
26. Lia Y.-P., Yuan-Ying X.-Y., Zhang Z.-H., Gub Z.-H., Zhoub W.-F., Yuanb J.-J., Zhoub J.-H., Zhua X.-J., Gaoa PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Controlled Release 2001, 71:203-211.
27. Mascolo D.D., Lyon C., Aryal S., Ramirez M.R., Wang J., Candeloro P., Guindani M., Hsueh W.A., Decuzzi P. Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity. J. Controlled Release 2013, 170:460-468.
28. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 1986, 46:6387-6392.
29. Naahidi S., Jafari M., Edalat F., Raymond K., Khademhosseini A., Chen P. Biocompatibility of engineered nanoparticles for drug delivery. J. Controlled Release 2013, 166:182-194.
30. Needham D. Reverse engineering the low temperature sensitive liposome (LTSL) for treating cancer. Biomaterials for Cancer Therapeutics 2013, Woodhead Publishing Ltd., Oxford, UK. K. Park (Ed.).
31. Paoli E.E., Ingham E.S., Zhang H., Mahakian L.M., Fite B.Z., Gagnon M.K., Tam S., Kheirolomoom A., Cardiff R.D., Ferrara K.W. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. J. Controlled Release 2014, 178:108-117.
32. Park K. Facing the truth about nanotechnology in drug delivery. ACS Nano 2013, 7:7442-7447.
33. Peiris P.M., Toy R., Abramowski A., Vicente P., Tucci S., Bauer L., Mayer A., Tam M., Doolittle E., Pansky J., Tran E., Lin D., Schiemann W.P., Ghaghada K.B., Griswold M.A., Karathanasis E. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J. Controlled Release 2014, 173:51-58.
34. Peltonen L., Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J. Pharm. Pharmacol. 2010, 62:1569-1579.
35. Ruzer L.S. Unattached fraction of radon progeny as an experimental tool in the assessment of the risk of nanoparticles. Aerosol Handbook: Measurement, Dosimetry, and Health Effects 2013, 415-438. CRS Press, Taylor & Francis Group, Baca Raton, FL. second ed. L.S. Ruzer, N.H. Harley (Eds.).
36. Sanches P.G., Rossin R., Böhmer M., Tiemann K., Grüll H. Real-time imaging and kinetics measurements of focused ultrasound-induced extravasation in skeletal muscle using SPECT/CT. J. Controlled Release 2013, 168:262-270.
37. Stirland D.L., Nichols J., Miura S., Bae Y.H. Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. J. Controlled Release 2013, 172:1045-1064.
38. Thanki K., Gangwal R.P., Sangamwar A.T., Jain S. Oral delivery of anticancer drugs: challenges and opportunities. J. Controlled Release 2013, 170:15-40.
39. Thoma C.R., Zimmermann M., Agarkova I., Kelm J.M., Krek W. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv. Drug Deliv. Rev. 2014, 69-70:29-41.
40. Vert M., Doi Y., Hellwich K.-H., Hess M., Hodge P., Kubisa P., Rinaudo M., Schué F. Terminology for biorelated polymers and applications (IUPAC Recommendations. Pure Appl. Chem. 2012, 84(2012):377-410.
41. Wacker M. Nanocarriers for intravenous injection-the long hard road to the market. Int. J. Pharm. 2013, 457:50-62.
42. Weinberg R.A. The Biology of Cancer 2013, Garland Science, New York, NY. second ed.
43. Wilczewska A.Z., Niemirowicz K., Markiewicz K.H., Car H. Nanoparticles as drug delivery systems. Pharmacol. Rep. 2012, 64:1020-1037.
44. Xiao H., Noble G.T., Stefanick J.F., Qi R., Kiziltepe T., Jing X., Bilgicer B. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo. J. Controlled Release 2014, 173:11-17.
45. Yudina A., Lepetit-Coiffé M., De Smet M., Langereis S., Grüll H., Moonen C. in vivo temperature controlled ultrasound-mediated intracellular delivery of cell-impermeable compounds. J. Controlled Release 2012, 161:90-97.
46. Zhang L., Gu F.X., Chan J.M., Wang A.Z., Langer R.S., Farokhzad O.C. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 2008, 83:761-769.
47. Zhang Y., Chan H.F., Leong K.W. Advanced materials and processing for drug delivery: the past and the future. Adv. Drug Deliv. Rev. 2013, 65:104-120.